We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Age of Stored Blood Affects Cardiac Surgery Success

By HospiMedica staff writers
Posted on 31 Mar 2008
A new study has found that cardiac surgery patients who received transfusions of blood that had been stored for 2 weeks or less had lower rates of complications and death than those who received blood that was older.

Researchers at the Cleveland Clinic Foundation (OH, USA) examined data from 6,002 patients given red blood cell (RBC) transfusions during coronary artery bypass grafting (CABG), heart-valve surgery, or both between June 30, 1998, and January 30, 2006. More...
The researchers compared a total 2,872 cardiac surgery patients who received transfusion blood that had been donated within the previous 2 weeks with 3,130 cardiac surgery patients who received transfusion blood that had been donated more than 2 weeks earlier. Multivariable logistic regression with propensity-score methods was used to examine the effect of the duration of storage on outcomes.

The researchers found that the patients who were given older blood had a higher risk of dying in hospital than their newer blood counterparts were (2.8% versus 1.7%), and significantly more likely to need prolonged ventilation support, experience kidney failure, sepsis, or multiple organ failure. Mortality at one year was significantly less in patients given newer blood (7.4%) compared to those given older blood (11%). The investigators also discovered a direct dose response relationship between days of storage and the chances of a combination of serious complications or adverse events. After eliminating potential confounding factors, an analysis revealed that patients who had received older blood had a significantly higher rate of combined serious adverse events than those who received newer blood. The study was published in the March 20, 2008, issue of the New England Journal of Medicine (NEJM).

"In patients undergoing cardiac surgery, transfusion of red cells that had been stored for more than two weeks was associated with a significantly increased risk of postoperative complications as well as reduced short-term and long-term survival,” concluded lead author Colleen Koch, M.D., M.S., and colleagues of the department of cardiothoracic anesthesia.

Previous studies have already raised questions about the shelf life of donated blood and attendant risks to patients. Some hospitals have brought in new procedures to minimize the use of donated blood during cardiac surgery, such as reducing anemia before surgery, using drugs to stop bleeding during and after surgery, collecting blood lost by the patient during surgery to be reused, and even discharging patients with a lower than normal RBC count.


Related Links:
Cleveland Clinic Foundation

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Pediatric Cast Saw
CSP-201 Quietcast
New
Portable Digital Floor Scale
DR400C
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.